These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

958 related items for PubMed ID: 15764953

  • 21. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 22. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 23. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
    Gascon RL, Narváez AB, Zhang R, Kahn JO, Hecht FM, Herndier BG, McGrath MS.
    J Acquir Immune Defic Syndr; 2002 Jun 01; 30(2):146-53. PubMed ID: 12045676
    [Abstract] [Full Text] [Related]

  • 24. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
    Marchetti G, Merlini E, Sinigaglia E, Iannotti N, Bai F, Savoldi A, Tincati C, Carpani G, Bini T, Arminio Monforte A.
    Curr HIV Res; 2012 Oct 01; 10(7):597-605. PubMed ID: 22716104
    [Abstract] [Full Text] [Related]

  • 25. Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.
    Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, Moore CB, Margolick J, Moss WJ.
    J Acquir Immune Defic Syndr; 2014 Dec 15; 67(5):455-62. PubMed ID: 25226208
    [Abstract] [Full Text] [Related]

  • 26. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC.
    J Acquir Immune Defic Syndr; 1999 Sep 01; 22(1):19-30. PubMed ID: 10534143
    [Abstract] [Full Text] [Related]

  • 27. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandström E.
    Cytometry; 1998 Oct 01; 33(2):115-22. PubMed ID: 9773871
    [Abstract] [Full Text] [Related]

  • 28. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    Cohen Stuart JW, Hazebergh MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ.
    J Acquir Immune Defic Syndr; 2000 Nov 01; 25(3):203-11. PubMed ID: 11115950
    [Abstract] [Full Text] [Related]

  • 29. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy.
    Koblavi-Dème S, Maran M, Kabran N, Borget MY, Kalou M, Kestens L, Maurice C, Sassan-Morokro M, Ekpini ER, Roels TH, Chorba T, Nkengasong JN.
    AIDS; 2003 Jul 01; 17 Suppl 3():S17-22. PubMed ID: 14565605
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 31. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
    Resino S, Galán I, Pérez A, León JA, Seoane E, Gurbindo D, Muñoz-Fernandez MA.
    Clin Exp Immunol; 2004 Sep 15; 137(3):570-7. PubMed ID: 15320908
    [Abstract] [Full Text] [Related]

  • 32. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.
    J Clin Immunol; 2003 Jul 15; 23(4):279-89. PubMed ID: 12959220
    [Abstract] [Full Text] [Related]

  • 33. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P, Hammann C, Kaufmann D, Battegay M, Rutschmann OT.
    Clin Exp Immunol; 1999 Mar 15; 115(3):458-63. PubMed ID: 10193418
    [Abstract] [Full Text] [Related]

  • 34. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
    Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D.
    Blood; 2000 Jan 01; 95(1):249-55. PubMed ID: 10607709
    [Abstract] [Full Text] [Related]

  • 35. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
    Nicholson JK, Browning SW, Hengel RL, Lew E, Gallagher LE, Rimland D, McDougal JS.
    J Acquir Immune Defic Syndr; 2001 Jun 01; 27(2):105-15. PubMed ID: 11404531
    [Abstract] [Full Text] [Related]

  • 36. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, Landay A, Kovacs A.
    J Infect Dis; 2006 May 01; 193(9):1202-10. PubMed ID: 16586355
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
    Al-Harthi L, Voris J, Patterson BK, Becker S, Eron J, Smith KY, D'Amico R, Mildvan D, Snidow J, Pobiner B, Yau L, Landay A.
    HIV Med; 2004 Jan 01; 5(1):55-65. PubMed ID: 14731171
    [Abstract] [Full Text] [Related]

  • 38. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
    Resino S, Abad ML, Navarro J, Bellón JM, Sánchez-Ramón S, Angeles Muñoz-Fernández M.
    Clin Exp Immunol; 2003 Jan 01; 131(1):130-7. PubMed ID: 12519396
    [Abstract] [Full Text] [Related]

  • 39. Nucleoside-free boosted double PI regimen: significant CD4+ T-cell recovery in patients with poor immunologic response despite virologic suppression.
    Lehmann C, Jung N, Hofmann A, Cornely OA, Wyen C, Fätkenheuer G, Hartmann P.
    Curr HIV Res; 2008 Nov 01; 6(6):555-9. PubMed ID: 18991621
    [Abstract] [Full Text] [Related]

  • 40. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y, Luo Y, He Y, Zheng Y, Zhang Q, Zhou H, Zeng S, Chen Z, He B, He M.
    AIDS Res Hum Retroviruses; 2013 Apr 01; 29(4):691-7. PubMed ID: 23151174
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.